RESUMEN
INTRODUCTION: In 2018, the Mozambique Ministry of Health launched guidelines for implementing differentiated service delivery models (DSDMs) to optimize HIV service delivery, improve retention in care, and ultimately reduce HIV-associated mortality. The models were fast-track, 3-month antiretrovirals dispensing, community antiretroviral therapy groups, adherence clubs, family approach and three one-stop shop models: adolescent-friendly health services, maternal and child health, and tuberculosis. We conducted a cost-effectiveness analysis and budget impact analysis to compare these models to conventional services. METHODS: We constructed a decision tree model based on the percentage of enrolment in each model and the probability of the outcome (12-month retention in treatment) for each year of the study period-three for the cost-effectiveness analysis (2019-2021) and three for the budget impact analysis (2022-2024). Costs for these analyses were primarily estimated per client-year from the health system perspective. A secondary cost-effectiveness analysis was conducted from the societal perspective. Budget impact analysis costs included antiretrovirals, laboratory tests and service provision interactions. Cost-effectiveness analysis additionally included start-up, training and clients' opportunity costs. Effectiveness was estimated using an uncontrolled interrupted time series analysis comparing the outcome before and after the implementation of the differentiated models. A one-way sensitivity analysis was conducted to identify drivers of uncertainty. RESULTS: After implementation of the DSDMs, there was a mean increase of 14.9 percentage points (95% CI: 12.2, 17.8) in 12-month retention, from 47.6% (95% CI, 44.9-50.2) to 62.5% (95% CI, 60.9-64.1). The mean cost difference comparing DSDMs and conventional care was US$ -6 million (173,391,277 vs. 179,461,668) and -32.5 million (394,705,618 vs. 433,232,289) from the health system and the societal perspective, respectively. Therefore, DSDMs dominated conventional care. Results were most sensitive to conventional care interaction costs in the one-way sensitivity analysis. For a population of 1.5 million, the base-case 3-year financial costs associated with the DSDMs was US$550 million, compared with US$564 million for conventional care. CONCLUSIONS: DSDMs were less expensive and more effective in retaining clients 12 months after antiretroviral therapy initiation and were estimated to save approximately US$14 million for the health system from 2022 to 2024.
Asunto(s)
Análisis Costo-Beneficio , Infecciones por VIH , Mozambique , Humanos , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/economía , Atención a la Salud/economía , Femenino , Fármacos Anti-VIH/uso terapéutico , Fármacos Anti-VIH/economía , Árboles de Decisión , Adolescente , MasculinoRESUMEN
Emerging zoonotic diseases are an increasing threat to public health. There is little data on the seroprevalence of zoonotic diseases among pastoralists in the country. We aim to carry out a cross-sectional study on the prevalence of major zoonotic diseases among pastoral communities in the Caia and Búzi districts. Methods: Between January and December 2018, a questionnaire was used to solicit socio-demographic data from consenting pastoralists with the collection of blood samples in the Caia and Búzi districts of the Sofala province. All samples were tested using ELISA commercial reagents for the detection of IgM antibodies against Brucella and Leptospira. Likewise, IgM and IgG antibodies against Rickettsia and CCHFV were determined using ELISA kits. Results: A total of 218 samples were tested, of which 43.5% (95/218) were from the district of Caia and 56.4% (123/218) from the Búzi district. Results from both districts showed that the seroprevalence of IgM antibodies against Brucella and Leptospira was 2.7% (6/218) and 30.3% (67/218), respectively. Positivity rates for IgM and IgG anti-Rickettsia and CCHFV were 8.7% (19/218), 2.7% (6/218), 4.1% (9/218), and 0.9% (2/218), respectively. Conclusions: Results from our study showed evidence of antibodies due to exposure to Brucella, Leptospira, Rickettsia, and CCHFV with antibodies against Leptospira and Rickettsia being the most prevalent. Hence, laboratory diagnosis of zoonotic diseases is essential in the early detection of outbreaks, the identification of silent transmission, and the etiology of non-febrile illness in a pastoral community. There is a need to develop public health interventions that will reduce the risk of transmission.
Asunto(s)
Humanos , Masculino , Femenino , Brucella/virología , Fiebre Hemorrágica de Crimea/virología , Anticuerpos Antivirales/inmunología , Rickettsia/crecimiento & desarrollo , Virus Hantaan/inmunología , Fiebre Hemorrágica de Crimea/prevención & control , Leptospira/virología , MozambiqueRESUMEN
Sub-Saharan Africa lacks timely, reliable, and accurate national data on mortality and causes of death (CODs). In 2018 Mozambique launched a sample registration system (Countrywide Mortality Surveillance for Action [COMSA]-Mozambique), which collects continuous birth, death, and COD data from 700 randomly selected clusters, a nationally representative population of 828,663 persons. Verbal and social autopsy interviews are conducted for COD determination. We analyzed data collected in 2019-2020 to report mortality rates and cause-specific fractions. Cause-specific results were generated using computer-coded verbal autopsy (CCVA) algorithms for deaths among those age 5 years and older. For under-five deaths, the accuracy of CCVA results was increased through calibration with data from minimally invasive tissue sampling. Neonatal and under-five mortality rates were, respectively, 23 (95% CI: 18-28) and 80 (95% CI: 69-91) deaths per 1,000 live births. Mortality rates per 1,000 were 18 (95% CI: 14-21) among age 5-14 years, 26 (95% CI: 20-31) among age 15-24 years, 258 (95% CI: 230-287) among age 25-59 years, and 531 (95% CI: 490-572) among age 60+ years. Urban areas had lower mortality rates than rural areas among children under 15 but not among adults. Deaths due to infections were substantial across all ages. Other predominant causes by age group were prematurity and intrapartum-related events among neonates; diarrhea, malaria, and lower respiratory infections among children 1-59 months; injury, malaria, and diarrhea among children 5-14 years; HIV, injury, and cancer among those age 15-59 years; and cancer and cardiovascular disease at age 60+ years. The COMSA-Mozambique platform offers a rich and unique system for mortality and COD determination and monitoring and an opportunity to build a comprehensive surveillance system.
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Adulto Joven , Enfermedades Cardiovasculares , Muerte , Mozambique/epidemiología , Causas de Muerte , NeoplasiasRESUMEN
The Countrywide Mortality Surveillance for Action platform is collecting verbal autopsy (VA) records from a nationally representative sample in Mozambique. These records are used to estimate the national and subnational cause-specific mortality fractions (CSMFs) for children (1-59 months) and neonates (1-28 days). Cross-tabulation of VA-based cause-of-death (COD) determination against that from the minimally invasive tissue sampling (MITS) from the Child Health and Mortality Prevention project revealed important misclassification errors for all the VA algorithms, which if not accounted for will lead to bias in the estimates of CSMF from VA. A recently proposed Bayesian VA-calibration method is used that accounts for this misclassification bias and produces calibrated estimates of CSMF. Both the VA-COD and the MITS-COD can be multi-cause (i.e., suggest more than one probable COD for some of the records). To fully use this probabilistic COD data, we use the multi-cause VA calibration. Two different computer-coded VA algorithms are considered-InSilicoVA and EAVA-and the final CSMF estimates are obtained using an ensemble calibration that uses data from both the algorithms. The calibrated estimates consistently offer a better fit to the data and reveal important changes in the CSMF for both children and neonates in Mozambique after accounting for VA misclassification bias.
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Niño , Muerte , Autopsia , Teorema de Bayes , Causas de Muerte , Mozambique/epidemiologíaRESUMEN
Mortality data, especially concerning deaths by cause, are critical for understanding the burden of disease, planning and monitoring of interventions aimed at reducing morbidity and mortality, as well as monitoring the Sustainable Development Goals for health (goal 3). In sub-Saharan Africa and most limited resource settings where burdens of diseases are high, there is a chronic lack of accurate and reliable data on mortality and causes of death. In these settings, complete diagnostic autopsy is only available in large hospitals and is unaffordable to most people. In addition, most deaths occur at the community level, and for facility deaths, physician medical certification of cause of death using medical information is not systematically completed. Available recent mortality and cause-of-death statistics are mostly based on modeling or periodic national surveys. Although they represent important tools, the uncertainty or long time intervals associated with their estimates challenge their use for precise or timely policy and program planning. Progressive efforts undertaken by low- and middle-income countries (LMICs) to revamp and expand their civil registration and vital statistics (CRVS) systems are commendable and timely. However, the time and resource needs in terms of infrastructure, technology, equipment, human resources, and demand creation to reach the entire population with a fully functional CRVS system are enormous and deprioritized in favor of more pressing demands in health care. The recent COVID-19 pandemic and emergence of epidemics across LMICs unveiled the vulnerabilities and challenges associated with the lack of or weak mortality data systems that can support planning, monitoring, and decision-making in these countries. In this context, building sustainable and resilient mortality surveillance systems that provide high-quality and timely mortality data represents a priority in Africa, as recently expressed in a newly developed continental framework for strengthening mortality surveillance in Africa by the Africa CDC.
Asunto(s)
Humanos , Estadísticas Vitales , Mozambique/epidemiologíaRESUMEN
Sub-Saharan Africa lacks timely, reliable, and accurate national data on mortality and causes of death (CODs). In 2018 Mozambique launched a sample registration system (Countrywide Mortality Surveillance for Action [COMSA]-Mozambique), which collects continuous birth, death, and COD data from 700 randomly selected clusters, a nationally representative population of 828,663 persons. Verbal and social autopsy interviews are conducted for COD determination. We analyzed data collected in 20192020 to report mortality rates and cause-specific fractions. Causespecific results were generated using computer-coded verbal autopsy (CCVA) algorithms for deaths among those age 5 years and older. For under-five deaths, the accuracy of CCVA results was increased through calibration with data from minimally invasive tissue sampling. Neonatal and under-five mortality rates were, respectively, 23 (95% CI: 1828) and 80 (95% CI: 6991) deaths per 1,000 live births. Mortality rates per 1,000 were 18 (95% CI: 1421) among age 514 years, 26 (95% CI: 2031) among age 1524 years, 258 (95% CI: 230287) among age 2559 years, and 531 (95% CI: 490572) among age 601 years. Urban areas had lower mortality rates than rural areas among children under 15 but not among adults. Deaths due to infections were substantial across all ages. Other predominant causes by age group were prematurity and intrapartum-related events among neonates; diarrhea, malaria, and lower respiratory infections among children 159 months; injury, malaria, and diarrhea among children 514 years; HIV, injury, and cancer among those age 1559 years; and cancer and cardiovascular disease at age 601 years. The COMSA-Mozambique platform offers a rich and unique system for mortality and COD determination and monitoring and an opportunity to build a comprehensive surveillance system.
Asunto(s)
Humanos , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Adulto Joven , Enfermedades Cardiovasculares , Neoplasias , Mortalidad , Causas de Muerte , Mozambique/epidemiologíaRESUMEN
We detected Bombali ebolavirus RNA in 3 free-tailed bats (Mops condylurus, Molossidae) in Mozambique. Sequencing of the large protein gene revealed 98% identity with viruses previously detected in Sierra Leone, Kenya, and Guinea. Our findings further support the suspected role of Mops condylurus bats in maintaining Bombali ebolavirus
Asunto(s)
Humanos , Animales , Ebolavirus/crecimiento & desarrollo , Ebolavirus/genética , Quirópteros , Ebolavirus/aislamiento & purificación , Mozambique/epidemiologíaRESUMEN
In mid-June 2019, 3 months after cyclone Idai landfall in Mozambique, health authorities of Nhamatanda district reported an outbreak of Pellagra. Applying a mixed-method protocol, we carried out an investigation to characterize cases of pellagra, identify the associated factors for the outbreak using a casecontrol study, and explore the perceived impact on food security (availability, access, and usage) before and after Idai. We collected data from 121 cases and 121 controls and conducted in-depth interviews with 69 heads of households. The cases were more likely to be female (P < 0.01) and less educated (P < 0.01) than controls. Insufficient consumption of chicken and peanut before cyclone Idai arrival were statistically associated with pellagra (P < 0.05). From interviewed households' heads, 51% were experiencing food shortages even before the cyclone hit. Cyclone Idai served as a trigger to reduce niacin consumption below the threshold that protected Nhamatanda population from pellagra and caused a 2,300 case (707.9/100,000 inhabitants) outbreak...
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Pelagra/etiología , Pelagra/epidemiología , Brotes de Enfermedades , Tormentas Ciclónicas , Piel/patología , Probabilidad , Mozambique/epidemiologíaRESUMEN
Background Poor patient experience, including long waiting time, is a potential reason for low healthcare utilisation. In this study, we evaluate the impact of appointment scheduling on waiting time and utilisation of antenatal care. Methods We implemented a pilot study in Mozambique introducing appointment scheduling to three maternity clinics, with a fourth facility used as a comparison. The intervention provided women with a return date and time for their next antenatal care visit. Waiting times and antenatal care utilisation data were collected in all study facilities. We assessed the effect of changing from first come, first served to scheduled antenatal care visits on waiting time and complete antenatal care (≥4 visits during pregnancy). Our primary analysis compared treatment facilities over time; in addition, we compared the treatment and comparison facilities using difference in differences. Results We collected waiting time data for antenatal care from 6918 women, and antenatal care attendance over the course of pregnancy from 8385 women. Scheduling appointments reduced waiting time for antenatal care in treatment facilities by 100 min (95% CI −107.2 to -92.9) compared with baseline. Using administrative records, we found that exposure to the scheduling intervention during pregnancy was associated with an approximately 16 percentage point increase in receipt of four or more antenatal care visits during pregnancy. Conclusions Relatively simple improvements in the organisation of care that reduce waiting time may increase utilisation of healthcare during pregnancy. A larger scale study is needed to provide information about whether appointment scheduling can be sustained over time
Asunto(s)
Pacientes , Citas y Horarios , Atención Prenatal , Terapéutica , Tiempo , Mujeres , Proyectos Piloto , Registros , Atención a la Salud , Cursos , Métodos , MozambiqueRESUMEN
The literature on sero-epidemiological studies of flaviviral infections in the African continent is quite scarce. Much of the viral epidemiology studies have been focussing on diseases such as HIV/AIDS because of their sheer magnitude and impact on the lives of people in the various affected countries. Increasingly disease outbreaks caused by arboviruses such as the recent cases of chikungunya virus, dengue virus and yellow fever virus have prompted renewed interest in studying these viruses. International agencies from the US, several EU nations and China are starting to build collaborations to build capacity in many African countries together with established institutions to conduct these studies. The Tofo Advanced Study Week (TASW) was established to bring the best scientists from the world to the tiny seaside town of Praia do Tofo to rub shoulders with African virologists and discuss cutting-edge science and listen to the work of researchers in the field. In 2015 the 1st TASW focussed on Ebola virus. The collections of abstracts from participants at the 2nd TASW which focused on Dengue and Zika virus as well as presentations on other arboviruses are collated in this chapter.
Asunto(s)
Humanos , Masculino , Femenino , Infecciones por Arbovirus/epidemiología , Infecciones por Arbovirus/sangre , Infecciones por Arbovirus/virología , Arbovirus/aislamiento & purificación , Arbovirus/genética , Arbovirus/inmunología , Estudios Seroepidemiológicos , África/epidemiología , Anticuerpos Antivirales/sangreRESUMEN
Background: On 9 January 2015, in a rural town in Mozambique, >230 persons became sick and 75 died of an illness linked to drinking pombe, a traditional alcoholic beverage. Methods: An investigation was conducted to identify case patients and determine the cause of the outbreak. A case patient was defined as any resident of Chitima who developed any new or unexplained neurologic, gastrointestinal, or cardiovascular symptom from 9 January at 6:00 am through 12 January at 11:59 pm. We conducted medical record reviews, healthcare worker and community surveys, anthropologic and toxicologic investigations of local medicinal plants and commercial pesticides, and laboratory testing of the suspect and control pombe. Results: We identified 234 case patients; 75 (32%) died and 159 recovered. Overall, 61% of case patients were female (n = 142), and ages ranged from 1 to 87 years (median, 30 years). Signs and symptoms included abdominal pain, diarrhea, vomiting, and generalized malaise. Death was preceded by psychomotor agitation and abnormal posturing. The median interval from pombe consumption to symptom onset was 16 hours. Toxic levels of bongkrekic acid (BA) were detected in the suspect pombe but not the control pombe. Burkholderia gladioli pathovar cocovenenans, the bacteria that produces BA, was detected in the flour used to make the pombe. Conclusions: We report for the first time an outbreak of a highly lethal illness linked to BA, a deadly food-borne toxin in Africa. Given that no previous outbreaks have been recognized outside Asia, our investigation suggests that BA might be an unrecognized cause of toxic outbreaks globally...
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Ácido Bongcréquico/aislamiento & purificación , Bebidas Alcohólicas/microbiología , Incidentes con Víctimas en Masa/mortalidad , Enfermedades Transmitidas por los Alimentos/mortalidad , Brotes de Enfermedades , Enfermedades Transmitidas por los Alimentos/microbiología , Mozambique/epidemiologíaRESUMEN
Background: On 9 January 2015, in a rural town in Mozambique, >230 persons became sick and 75 died of an illness linked to drinking pombe, a traditional alcoholic beverage. Methods: An investigation was conducted to identify case patients and determine the cause of the outbreak. A case patient was defined as any resident of Chitima who developed any new or unexplained neurologic, gastrointestinal, or cardiovascular symptom from 9 January at 6:00 am through 12 January at 11:59 pm. We conducted medical record reviews, healthcare worker and community surveys, anthropologic and toxicologic investigations of local medicinal plants and commercial pesticides, and laboratory testing of the suspect and control pombe. Results: We identified 234 case patients; 75 (32%) died and 159 recovered. Overall, 61% of case patients were female (n = 142), and ages ranged from 1 to 87 years (median, 30 years). Signs and symptoms included abdominal pain, diarrhea, vomiting, and generalized malaise. Death was preceded by psychomotor agitation and abnormal posturing. The median interval from pombe consumption to symptom onset was 16 hours. Toxic levels of bongkrekic acid (BA) were detected in the suspect pombe but not the control pombe. Burkholderia gladioli pathovar cocovenenans, the bacteria that produces BA, was detected in the flour used to make the pombe. Conclusions: We report for the first time an outbreak of a highly lethal illness linked to BA, a deadly food-borne toxin in Africa. Given that no previous outbreaks have been recognized outside Asia, our investigation suggests that BA might be an unrecognized cause of toxic outbreaks globally.
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Ácido Bongcréquico/aislamiento & purificación , Burkholderia gladioli/aislamiento & purificación , Bebidas Alcohólicas/microbiología , Incidentes con Víctimas en Masa/mortalidad , Enfermedades Transmitidas por los Alimentos/mortalidad , Población Rural , Brotes de Enfermedades , Harina/microbiología , Enfermedades Transmitidas por los Alimentos/microbiología , Mozambique/epidemiologíaRESUMEN
Objective: Despite its geographical spread, the epidemiology of Crimean-Congo haemorrhagic fever (CCHF) in Sub-Saharan Africa is incompletely understood and its occurrence in Mozambique is unknown. This study was conducted with the aim of investigating the occurrence of CCHF virus (CCHFV) among febrile patients attending an outpatient appointment clinic at three separate primary health care centres in Mozambique. Methods: Serum samples were collected from a total of 300 febrile patients aged >5 years who were recruited between March 2015 and March 2016 at three health centres in Mozambique. Each patient was screened for IgG antibodies against CCHFV using an ELISA. Results: Of the 300 patients enrolled, eight had samples that were positive for anti-CCHFV IgG antibodies, yielding a prevalence rate of 2.7%. Conclusions: This study shows for the first time that humans are exposed to CCHFV in Mozambique. It highlights the need for further work to investigate the broader extent of circulating CCHFV in the country and its clinical implications...
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano de 80 o más Años , Ensayo de Inmunoadsorción Enzimática , Virus de la Fiebre Hemorrágica de Crimea-Congo/inmunología , Fiebre Hemorrágica de Crimea/diagnóstico , Fiebre Hemorrágica de Crimea/sangre , Inmunoglobulina G/inmunología , Fiebre Hemorrágica de Crimea/epidemiología , Anticuerpos Antivirales , Anticuerpos Antivirales/inmunología , Anticuerpos Antivirales/sangre , MozambiqueRESUMEN
Background: Internationally-accredited laboratories are recognised for their superior test reliability, operational performance, quality management and competence. In a bid to meet international quality standards, the Mozambique National Institute of Health enrolled the National Tuberculosis Reference Laboratory (NTRL) in a continuous quality improvement process towards ISO 15189 accreditation. Here, we describe the road map taken by the NTRL to achieve international accreditation. Methods: The NTRL adopted the Strengthening Laboratory Management Toward Accreditation (SLMTA) programme as a strategy to implement a quality management system. After SLMTA, the Mozambique National Institute of Health committed to accelerate the NTRL's process toward accreditation. An action plan was designed to streamline the process. Quality indicators were defined to benchmark progress. Staff were trained to improve performance. Mentorship from an experienced assessor was provided. Fulfilment of accreditation standards was assessed by the Portuguese Accreditation Board. Results: Of the eight laboratories participating in SLMTA, the NTRL was the best-performing laboratory, achieving a 53.6% improvement over the SLMTA baseline conducted in February 2011 to the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) assessment in June 2013. During the accreditation assessment in September 2014, 25 minor nonconformities were identified and addressed. In March 2015, the NTRL received Portuguese Accreditation Board recognition of technical competency for fluorescence smear microscopy, and solid and liquid culture. The NTRL is the first laboratory in Mozambique to achieve ISO 15189 accreditation. Conclusions: From our experience, accreditation was made possible by institutional commitment, strong laboratory leadership, staff motivation, adequate infrastructure and a comprehensive action plan.
Asunto(s)
Humanos , Masculino , Femenino , Tuberculosis , Laboratorios , MozambiqueRESUMEN
Background: Although Chikungunya virus has rapidly expanded to several countries in sub-Saharan Africa, little attention has been paid to its control and management. Until recently, Chikungunya has been regarded as a benign and self-limiting disease. In this report we describe the first case of severe Chikungunya disease in an adult patient in Pemba, Mozambique. Case presentation: A previously healthy 40 year old male of Makonde ethnicity with no known past medical history and resident in Pemba for the past 11 years presented with a severe febrile illness. Despite administration of broad spectrum intravenous antibiotics the patient rapidly deteriorated and became comatose while developing anaemia, thrombocytopenia and later, melaena. Laboratory testing revealed IgM antibodies against Chikungunya virus. Malaria tests were consistently negative. Conclusions: This report suggests that Chikungunya might cause unsuspected severe disease in febrile patients in Mozambique and provides insights for the improvement of national protocols for management of febrile patients in Mozambique. We recommend that clinicians should consider Chikungunya in the differential diagnosis of febrile illness in locations where Aedes aegypti mosquitos are abundant...
Asunto(s)
Animales , Adolescente , Índice de Severidad de la Enfermedad , Melena/diagnóstico , Fiebre/diagnóstico , Fiebre Chikungunya/diagnóstico , Leucocitosis/diagnóstico , Antibacterianos , Inmunoglobulina M/sangre , Melena/patología , Melena/terapia , Melena/virología , Fiebre/parasitología , Fiebre/terapia , Fiebre/virología , Fiebre Chikungunya , Fiebre Chikungunya/parasitología , Fiebre Chikungunya/terapia , Fiebre Chikungunya/virología , Leucocitosis/terapia , Leucocitosis/virología , MozambiqueRESUMEN
After the report of an outbreak of dengue virus serotype 2 in 2014 in Nampula and Pemba cities, northernMozambique, a surveillance system was established by the National Institute of Health. A study was performed during20152016 to monitor the trend of the outbreak and confirm the circulating serotype of dengue virus (DENV). After theinclusion of consenting patients who met the case definition, samples from 192 patients were tested for the presence ofnonstructural protein1antigen,and60/192(31%)sampleswerepositive.FurtheranalysisincludedDENVIgMantibodies,with 39 (20%) IgM positive cases. Reverse transcriptase (RT) PCR was performed for identification of the prevailing DENVserotype; 21/23 tested samples were DENV-2 positive, with DENV-2 present in both affected cities. When sequencingDENV, phenotype Cosmopolitan was identified. The surveillance indicates ongoing spread of DENV-2 in northernMozambique 2 years after thefirst report of the outbreak.
Asunto(s)
Humanos , Virus del Dengue , Pacientes , Manejo de Especímenes , Reacción en Cadena de la Polimerasa , ADN Polimerasa Dirigida por ARN , Sistema de Vigilancia Sanitaria , Serogrupo , Anticuerpos , AntígenosRESUMEN
Although Kokernot et al. found neutralizing antibodies against ZIKV in Mozambique in 1957 [20], the country has repeatedly been excluded from the list of countries with a past history of ZIKV. The current Centers for Disease Control and Prevention map, the recent World Health Organization Risk Assessment map on ZIKV in the Africa region, and most of the recent literature mapping countries with a current and past history of ZIKV have consistently excluded Mozambique [10, 21, 22] from the list of countries with past serological evidence of ZIKV. This might result in errors in the calculation and interpretation of the risk of Zika in Mozambique as well as in the region. In this regard, in this manuscript we revisit findings of the study conducted by Kokernot et al. in an attempt to discuss the current risk of Zika in the country. The survey, conducted in 1957, was published in Portuguese in 1960 [20]. This study was part of a larger study on arboviruses, in which blood samples were screened for antibodies against 13 arboviruses, including ZIKV, chikungunya, Rift Valley fever, Sindbis, Middleburg, and Wesselsbron. Samples were collected in 29 localities situated widely apart from each other throughout the country between July and August 1957. In each locality, they selected an average of 30 local residents who had been born in the area with no history of travel outside in their lifetime. The samples were analyzed in South Africa, using confirmatory neutralization testing (NT). NT was performed using an in vivo system. For this purpose, previously titrated virus strains for each arbovirus being tested were incubated with each participant's serum and inoculated into Swiss mice to assess the neutralization profile of each serum against each virus strain. For ZIKV, the prototype ZIKV strain was used [18], and both adult and newborn mice were used for inoculation. An amount of 0.03 mL of the preparation virus and serum was inoculated intracerebrally, as previously described [18], and each mouse was observed daily between 10 17 days to assess the viral effect. The authors found neutralizing antibodies to all of the viruses and concluded that the whole length of Mozambique was a "tropical corridor" of arbovirus activity. The viruses with highest prevalence rates of neutralizing antibodies were chikungunya (21.0%), Wesselsbron (15.9%), Bunyamwera (24.1%), Pongola (23.2%) and Bwamba fever (24.7%)...
Asunto(s)
Humanos , Animales , Masculino , Femenino , Control de Mosquitos/historia , Infección por el Virus Zika/epidemiología , Mosquitos Vectores , Infección por el Virus Zika/historia , Mozambique/epidemiologíaRESUMEN
Background: S. pneumoniae is the leading cause of acute bacterial meningitis (ABM) in children. Vaccination using the 10-valent conjugate vaccine (PCV-10) was recently introduced into the National Immunization Program in Mozambique, but data on serotype coverage of this vaccine formulation are scarce. In this study, we investigated the serotype distribution and antimicrobial resistance of isolates of S. pneumoniae causing ABM in children < 5 years at the two largest hospitals in Mozambique. Methods: Between March 2013 and March 2014, a total of 352 cerebrospinal fluid (CSF) samples were collected from eligible children, of which 119 (33.8 %) were positive for S. pneumoniae. Of these, only 50 samples met the criteria for serotyping and were subsequently serotyped using sequential multiplex PCR (SM-PCR), but 15 samples were non-typable. Results: The most common serotypes of S. pneumoniae were 1 (18.2 %), 5 (15.2 %), 14 (12.1 %), 9 V (12.1 %), 23 F (9.1 %), 6A (9.1 %), 4 (9.1 %) and 6B (6.1 %). Serotypes 1, 5, 9 V, 6A and 12 were mostly prevalent in Northern Mozambique, while serotypes 23 F, 4, 6B, 3 and 15B were predominant in Southern. Serotype coverage of PCV-10 and PCV-13 vaccine formulations were 81.8 % and 93.9 %, respectively. Serotypes 1, 3, 4, 6B, 14, 23 F were resistant to penicillin and sensitive to ceftriaxone. Conclusions: Our findings shows that changing the current in use PCV-10 vaccine formulation to PCV-13 formulation might increase substantially the protection against invasive strains of S. pneumoniae as the PCV-10 vaccine formulation does not cover the serotypes 3 and 6A, which are prevalent in Mozambique...
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Adolescente , Streptococcus pneumoniae/clasificación , Meningitis Bacterianas/microbiología , Vacunas Neumococicas , Farmacorresistencia Bacteriana Múltiple , Antibacterianos/farmacología , Penicilinas/farmacología , Infecciones Neumocócicas/inmunología , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/aislamiento & purificación , Streptococcus pneumoniae/efectos de la radiación , Streptococcus pneumoniae/genética , Ceftriaxona/farmacología , ADN Bacteriano/análisis , Pruebas de Sensibilidad Microbiana , Reacción en Cadena de la Polimerasa , Meningitis Bacterianas/prevención & control , Meningitis Bacterianas/epidemiología , Vacunas Neumococicas/administración & dosificación , Monitoreo Epidemiológico , Mozambique/epidemiologíaRESUMEN
Background: Rift Valley fever virus (RVFV) remains heavily neglected in humans in Mozambique, even though recent outbreaks were reported in neighboring countries in humans and several cases of RVFV in cattle were reported in several districts in Mozambique. Findings: We conducted a cross sectional study during and after severe flooding that occurred in 2013 in Mozambique. Paired acute and convalescent serum samples were tested from febrile patients attending a primary health care unit in a suburban area of Maputo city for the presence of IgG and IgM antibodies against Rift Valley fever virus (RVFV) using enzyme-linked immunosorbent assay (ELISA). Seroconversion of IgG anti-RVFV was observed in 5 % (10/200) of convalescent patients and specific IgM anti-RVFV was detected in one acute patient (0.5 %; 1/200). All sera from acute patient tested negative by real time PCR. Conclusion: In conclusion, our results suggest that RVF represent an important but neglected cause of febrile illness following periods of flooding in southern Mozambique.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Fiebre del Valle del Rift/diagnóstico , Fiebre del Valle del Rift/epidemiología , Virus de la Fiebre del Valle del Rift/genética , Inmunoglobulina G , Ensayo de Inmunoadsorción Enzimática , Anticuerpos Antivirales , Virus de la Fiebre del Valle del Rift/inmunología , Pruebas Serológicas , Estudios Transversales , Reacción en Cadena en Tiempo Real de la Polimerasa , Mozambique , Mozambique/epidemiologíaRESUMEN
In sub-Saharan Africa, febrile patients are often assumed to have, and are treated for, malaria, but when tested, many are malaria-negative. Because emerging diseases, such as chikungunya virus (CHIKV) and dengue virus (DENV) infections, cause outbreaks around the world (13), the importance of these pathogens has become more evident. However, low-income countries have limited epidemiologic data on alternative diagnoses to malaria (4,5) and poor laboratory capacity (1), which restrict further diagnostic investigations. An early study in Mozambique during the 1980s found antibodies to Rift Valley fever virus (RVFV) in 2% of pregnant women (6). More recently, a RVFV seroprevalence of 36.9% among cattle in the Maputo Province was shown in 20102011 (7). Furthermore, the movement of humans from rural areas to major cities, particularly to the capital of Maputo, might affect human illnesses and disease pattern of zoonotic viruses (3). We conducted a pilot study on CHIKV, DENV, hantavirus, RVFV, and West Nile virus (WNV) epidemiology in Mozambique. Ethical approval (registration no. IRB00002657) was granted by the National Bioethics Committee in Mozambique and by the Regional Ethical Review Board at Karolinska Institutet, Stockholm, Sweden (permit no. 2012/97431/3)...